CDKN2A encodes proteins such as p16 (INK4a). which negatively regulate the cell-cycle. Molecular genetic studies have revealed that deletions in CDKN2A occur frequently in cancer. Although p16 (INK4a) may be involved in tumor progression. https://www.spidertattooz.com/